We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Plavix Linked to Lower Risk of Heart Attack
Plavix Linked to Lower Risk of Heart Attack
December 8, 2006
Patients implanted with drug-eluting stents who have not had cardiovascular events or additional procedures within six months of follow-up may benefit from extended use of sanofi-aventis’ blood-thinning drug Plavix, according to a study being published in the Jan. 10 issue of The Journal of the American Medical Association.